The Clinical Trials Transformation Initiative: innovation through collaboration

Pamela Tenaerts; Leanne Madre; Patrick Archdeacon; Robert M Califf

doi:10.1038/nrd4442

The Clinical Trials Transformation Initiative: innovation through collaboration

Nat Rev Drug Discov. 2014 Nov;13(11):797-8. doi: 10.1038/nrd4442.

Authors

Pamela Tenaerts¹, Leanne Madre¹, Patrick Archdeacon², Robert M Califf³

Affiliations

¹ Clinical Trials Transformation Initiative, Duke Translational Medicine Institute, 300 West Morgan Street, Suite 800, Durham, North Carolina 27701, USA.
² Office of Medical Policy, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland 20993, USA.
³ Duke Translational Medicine Institute, Durham, North Carolina 27710, USA.

PMID: 25359366
DOI: 10.1038/nrd4442

Abstract

The Clinical Trials Transformation Initiative (CTTI) identifies and promotes practices to increase the quality and efficiency of clinical trials through projects that generate empirical data on how trials are currently conducted, leading to recommendations for improvement.

MeSH terms

Clinical Trials as Topic*
Cooperative Behavior*
Humans
Randomized Controlled Trials as Topic
United States
United States Food and Drug Administration